M. J. Sonneveld Et Al. , "HBSAG LEVELS AT SIX MONTHS POST-TREATMENT PREDICT SUSTAINED RESPONSE THROUGH LONG-TERM FOLLOW-UP IN HBEAG-POSITIVE PATIENTS TREATED WITH PEGINTERFERON ALFA-2B," 62nd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) , vol.54, San-Francisco, Costa Rica, 2011
Sonneveld, M. J. Et Al. 2011. HBSAG LEVELS AT SIX MONTHS POST-TREATMENT PREDICT SUSTAINED RESPONSE THROUGH LONG-TERM FOLLOW-UP IN HBEAG-POSITIVE PATIENTS TREATED WITH PEGINTERFERON ALFA-2B. 62nd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) , (San-Francisco, Costa Rica).
Sonneveld, M. J., Rijckborst, V., Zoutendijk, R., Gerken, G., Tabak, F., Mach, T. H., ... Boucher, C. A.(2011). HBSAG LEVELS AT SIX MONTHS POST-TREATMENT PREDICT SUSTAINED RESPONSE THROUGH LONG-TERM FOLLOW-UP IN HBEAG-POSITIVE PATIENTS TREATED WITH PEGINTERFERON ALFA-2B . 62nd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), San-Francisco, Costa Rica
Sonneveld, Milan Et Al. "HBSAG LEVELS AT SIX MONTHS POST-TREATMENT PREDICT SUSTAINED RESPONSE THROUGH LONG-TERM FOLLOW-UP IN HBEAG-POSITIVE PATIENTS TREATED WITH PEGINTERFERON ALFA-2B," 62nd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), San-Francisco, Costa Rica, 2011
Sonneveld, Milan J. Et Al. "HBSAG LEVELS AT SIX MONTHS POST-TREATMENT PREDICT SUSTAINED RESPONSE THROUGH LONG-TERM FOLLOW-UP IN HBEAG-POSITIVE PATIENTS TREATED WITH PEGINTERFERON ALFA-2B." 62nd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) , San-Francisco, Costa Rica, 2011
Sonneveld, M. J. Et Al. (2011) . "HBSAG LEVELS AT SIX MONTHS POST-TREATMENT PREDICT SUSTAINED RESPONSE THROUGH LONG-TERM FOLLOW-UP IN HBEAG-POSITIVE PATIENTS TREATED WITH PEGINTERFERON ALFA-2B." 62nd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) , San-Francisco, Costa Rica.
@conferencepaper{conferencepaper, author={Milan J. Sonneveld Et Al. }, title={HBSAG LEVELS AT SIX MONTHS POST-TREATMENT PREDICT SUSTAINED RESPONSE THROUGH LONG-TERM FOLLOW-UP IN HBEAG-POSITIVE PATIENTS TREATED WITH PEGINTERFERON ALFA-2B}, congress name={62nd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD)}, city={San-Francisco}, country={Costa Rica}, year={2011}}